You are here: Industry Insights > injections

News List

Drug delivery on the go: Wearable delivery systems Suzanne Elvidge
July 03, 2024
Wearable drug delivery systems, also known as on-body systems, are designed to accurately deliver the right dose of a drug to the right place at the right time, via a pump and cannula or needle, or a drug delivery patch.
The Road to Long-acting Injectables Spuer 203
May 23, 2024
As a complex formulation, long-acting injectables are a class of long-acting sustained-release formulations in which a sufficient amount of drug is injected into the body and slowly released to allow the drug to continue to produce treatment.
Enable Injections, Genentech Enter Partnership contractpharma
August 22, 2019
enFuse technology allows patients to self-administer subcutaneous treatments outside of clinical setting.
First Human Study of "Robotic" RaniPill Capsule to Replace Injections Announced americanpharmaceuticalreview
March 01, 2019
The first human study of a pill designed to replace injections of biologics is today being announced by Rani Therapeutics, the inventor of the RaniPill™ capsule.
Amgen teams with Entera to develop oral biologics fiercebiotech
December 27, 2018
Amgen has struck a deal with Entera Bio to develop oral formulations of up to three large molecules. The agreement sees Amgen pay a “modest” upfront fee to access Entera’s technology and commit to up to $270 million in milestones.......
Enable Injections Partners with UCB and Apellis Pharmaceuticals contractpharma
November 14, 2018
Enable Injections Partners with UCB and Apellis Pharmaceuticals
Weekly injections shows HIV-1 viral suppression europeanpharmaceuticalreview
June 11, 2018
Results from a pivotal trial of a new HIV therapy, show that PRO 140 is an effective, long-acting therapeutic for previously treated HIV-1 infected patients…
Orthocell collaborates with J&J’s DePuy Synthes for Ortho-ATI approach pharmaceutical-technology
January 16, 2017
Regenerative medicine company Orthocell has announced plans to collaborate with DePuy Synthes Products, part of the Johnson & Johnson (J&J) family of companies, for its Ortho-ATI stem-cell approach.